DCF — BAYLOR UNIVERSITY MEDICAL CTR
Enterprise Value: $-203.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-203.6M
Enterprise Value
$-97.3M
PV of Cash Flows
$-106.3M
PV of Terminal Value
$-171.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.3B | $11.9M | 1.0% | $-43.0M | $-39.1M |
| Year 2 | $1.3B | $25.6M | 2.0% | $-30.9M | $-25.6M |
| Year 3 | $1.4B | $40.1M | 3.0% | $-19.5M | $-14.7M |
| Year 4 | $1.4B | $48.4M | 3.0% | $-14.8M | $-10.1M |
| Year 5 | $1.5B | $53.5M | 4.0% | $-12.5M | $-7.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-203.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.3B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0041586602295234
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5